only antiemetic drug

PreclinicalSmall molecule

TTianjin University of Traditional Chinese Medicine

only antiemetic drug is one of 32 small molecule programs targeting Chemotherapy-induced nausea and vomiting. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chemotherapy-Induced Nausea and VomitingActive, not recruiting

Chemotherapy-Induced Nausea and VomitingPreclinical

Active, not recruiting

Competition

Competitive Landscape

60 competitors in Chemotherapy-Induced Nausea and Vomiting

#DrugCompanyPhaseTrials

Zofran

Novartis

Approved

7 2

Emend

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

7 3

Decadron

AAspen Global Incorporated

Approved

6 4

Avelox

Bayer

Approved

—5

Aspercreme Warming

AAveritas Pharma, Inc.

Barhemsys

Remeron

Comparator: Pbo

1 9

Emend IV

Merck & Co.

Phase 3

3 10

Depo-Provera

Eli Lilly

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chemotherapy-induced nausea and vomiting3 trials

Acupuncture for Chemotherapy-Induced Nausea and Vomiting

Completed·TTianjin University of Traditional Chinese Medicine·N/A·NCT02195921·160 enrolled

Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting

Unknown status·TTianjin University of Traditional Chinese Medicine·N/A·NCT02478047·240 enrolled

The Different Effectiveness of Single Acupoint（PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting

Completed·TTianjin University of Traditional Chinese Medicine·N/A·NCT02195908·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for only antiemetic drug. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — only antiemetic drug compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for only antiemetic drug. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tianjin University of Traditional Chinese Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTianjin University of Traditional Chinese Medicine

only antiemetic drug

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chemotherapy-induced nausea and vomiting3 trials

References

Drug Info

Quick Facts

Related News